GNR-086

· AO Generium

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GNR-086, covering 2024-07-01 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease [Phase 3]

See pricing